Very interesting paper by the group of Jack Taunton in Nature. They used salicylaldehyde-based reactive groups to develop mutant-selective AKT1 (E17K) inhibitors. Key to selectivity is a very slow off-rate from the mutant due to neo-zinc chelation. https://www.nature.com/articles/s41586-024-08176-4
Comments